Literature DB >> 35586534

Do Patients with Progressive Supranuclear Palsy Have Episodic Memory Impairment? A Systematic Review.

Arthur Cassa Macedo1, Luciano Inácio Mariano1,2, Marina Isoni Martins2, Clarisse Vasconcelos Friedlaender1, Jesus Mística Ventura1,3, João Victor de Faria Rocha4, Sarah Teixeira Camargos2,3,5, Francisco Eduardo Costa Cardoso2,3,5, Paulo Caramelli1,2,5, Leonardo Cruz de Souza1,2,5.   

Abstract

Background: Progressive supranuclear palsy (PSP) is the most common atypical parkinsonism and has executive dysfunction as a core feature. The magnitude of episodic memory disturbance in PSP is yet to be clarified.
Objectives: To investigate how impaired is episodic memory in PSP compared to healthy controls and other neuropsychiatric disorders. Also, we sought to identify the brain correlates underlying these memory disturbances.
Methods: We performed a systematic search on PubMed and Scopus, combining the terms "progressive supranuclear palsy" AND "memory". The search was limited to papers published in English, French, Portuguese or Spanish, with no chronological filters. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed.
Results: The initial search returned 464 results. After extraction of duplicates, 356 records were screened, leading to inclusion of 38 studies. Most studies found that PSP patients had lower scores on episodic memory compared to healthy controls. In addition, the majority of studies suggest that PSP does not differ from Parkinson's disease and from atypical parkinsonism in terms of episodic memory performance. The same is seen for PSP and frontotemporal dementia. Conversely, episodic memory impairment seems to be greater in typical Alzheimer's disease compared to PSP. Neuroimaging findings indicate that striatofrontal structures may be involved in PSP episodic memory dysfunction, while no associations with mesial structures (including hippocampi) were found. Conclusions: Episodic memory is impaired in PSP. Whether this amnesia refers to executive dysfunction is still controversial. More studies are warranted to clarify the neural basis of memory impairment in PSP.
© 2022 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  episodic memory; parkinsonism; progressive supranuclear palsy

Year:  2022        PMID: 35586534      PMCID: PMC9092732          DOI: 10.1002/mdc3.13435

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN: 2330-1619


  71 in total

1.  A mosquito bites and a butterfly flies: A specific response type of frontal patients in a similarity task.

Authors:  Béatrice Garcin; Emmanuelle Volle; Aurélie Funkiewiez; Bruce L Miller; Bruno Dubois; Richard Levy
Journal:  Neuropsychologia       Date:  2018-06-26       Impact factor: 3.139

2.  Accuracy of the National Institute for Neurological Disorders and Stroke/Society for Progressive Supranuclear Palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy.

Authors:  Gesine Respondek; Sigrun Roeber; Hans Kretzschmar; Claire Troakes; Safa Al-Sarraj; Ellen Gelpi; Carles Gaig; Wang Zheng Chiu; John C van Swieten; Wolfgang H Oertel; Günter U Höglinger
Journal:  Mov Disord       Date:  2013-02-21       Impact factor: 10.338

3.  Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy.

Authors:  Richard G Brown; Lucette Lacomblez; Bernard G Landwehrmeyer; Thomas Bak; Ingo Uttner; Bruno Dubois; Yves Agid; Albert Ludolph; Gilbert Bensimon; Christine Payan; Nigel P Leigh
Journal:  Brain       Date:  2010-06-24       Impact factor: 13.501

4.  In vivo and post-mortem memory circuit integrity in frontotemporal dementia and Alzheimer's disease.

Authors:  Michael Hornberger; Stephanie Wong; Rachel Tan; Muireann Irish; Olivier Piguet; Jillian Kril; John R Hodges; Glenda Halliday
Journal:  Brain       Date:  2012-09-25       Impact factor: 13.501

5.  Are explicit memory disorders of progressive supranuclear palsy related to damage to striatofrontal circuits? Comparison with Alzheimer's, Parkinson's, and Huntington's diseases.

Authors:  B Pillon; B Deweer; A Michon; C Malapani; Y Agid; B Dubois
Journal:  Neurology       Date:  1994-07       Impact factor: 9.910

6.  Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy.

Authors:  Adam Gerstenecker; Benjamin Mast; Kevin Duff; Tanis J Ferman; Irene Litvan
Journal:  Arch Clin Neuropsychol       Date:  2012-11-04       Impact factor: 2.813

7.  Memory impairment in patients with progressive supranuclear palsy.

Authors:  I Litvan; J Grafman; C Gomez; T N Chase
Journal:  Arch Neurol       Date:  1989-07

8.  Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.

Authors:  Günter U Höglinger; Gesine Respondek; Maria Stamelou; Carolin Kurz; Keith A Josephs; Anthony E Lang; Brit Mollenhauer; Ulrich Müller; Christer Nilsson; Jennifer L Whitwell; Thomas Arzberger; Elisabet Englund; Ellen Gelpi; Armin Giese; David J Irwin; Wassilios G Meissner; Alexander Pantelyat; Alex Rajput; John C van Swieten; Claire Troakes; Angelo Antonini; Kailash P Bhatia; Yvette Bordelon; Yaroslau Compta; Jean-Christophe Corvol; Carlo Colosimo; Dennis W Dickson; Richard Dodel; Leslie Ferguson; Murray Grossman; Jan Kassubek; Florian Krismer; Johannes Levin; Stefan Lorenzl; Huw R Morris; Peter Nestor; Wolfgang H Oertel; Werner Poewe; Gil Rabinovici; James B Rowe; Gerard D Schellenberg; Klaus Seppi; Thilo van Eimeren; Gregor K Wenning; Adam L Boxer; Lawrence I Golbe; Irene Litvan
Journal:  Mov Disord       Date:  2017-05-03       Impact factor: 10.338

Review 9.  Cognition in corticobasal syndrome and progressive supranuclear palsy: a review.

Authors:  James R Burrell; John R Hodges; James B Rowe
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

10.  Association of Motor and Cognitive Symptoms with Health-Related Quality of Life and Caregiver Burden in a German Cohort of Advanced Parkinson's Disease Patients.

Authors:  M Klietz; T Schnur; S Drexel; F Lange; A Tulke; L Rippena; L Paracka; D Dressler; G U Höglinger; F Wegner
Journal:  Parkinsons Dis       Date:  2020-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.